- Trump pressured the FDA regarding product authorization, leading to the resignation of Marty Makary.
- The administration has signed an executive order and issued priority vouchers to accelerate the drug approval process through the FDA.
An HHS official commented on an FDA program, following Marty Makary's departure from the agency.
1 report, 1 independent
Updated 00:00
AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.
What happened
An HHS official commented on an FDA program, following Marty Makary's departure from the agency.
Who's involved
What this event is mainly aboutKeep exploring
The entities involved
- FDA
-
Department of Health & Human Services
government department in the state of Victoria, Australia